Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea.
- Published in:
- Eurosurveillance (15607917), 2020, v. 25, n. 43, p. 1, doi. 10.2807/1560-7917.ES.2020.25.43.1900210
- By:
- Publication type:
- Article
Works matching IS 1025496X AND DT 2020 AND VI 25 AND IP 43
Results: 4
1
2
Retrospective analysis on confirmation rates for referred positive rotavirus samples in England, 2016 to 2017: implications for diagnosis and surveillance.
- Published in:
- Eurosurveillance (15607917), 2020, v. 25, n. 43, p. 1, doi. 10.2807/1560-7917.ES.2020.25.43.1900375
- By:
- Publication type:
- Article
3
Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics.
- Published in:
- Eurosurveillance (15607917), 2020, v. 25, n. 43, p. 1, doi. 10.2807/1560-7917.ES.2020.25.43.1900402
- By:
- Publication type:
- Article
4
The contribution of HIV point-of-care tests in early HIV diagnosis: community-based HIV testing monitoring in Catalonia, 1995 to 2018.
- Published in:
- Eurosurveillance (15607917), 2020, v. 25, n. 43, p. 1, doi. 10.2807/1560-7917.ES.2020.25.43.1900424
- By:
- Publication type:
- Article